New Lis­te­ria fears spot­light­ed as Aduro’s CRS-207 is slapped with par­tial hold

Nag­ging fears that Aduro Biotech’s can­cer vac­cine CRS-207 could trig­ger se­ri­ous Lis­te­ria in­fec­tions mush­roomed in­to a se­vere set­back on Mon­day morn­ing as the biotech re­port­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.